self-management survivorship care in stage i-iii non-small cell lung cancer or colorectal cancer

Conditions: Lung Non-Small Cell Carcinoma; Stage I Colorectal Cancer AJCC v8; Stage I Lung Cancer AJCC v8; Stage IA1 Lung Cancer AJCC v8; Stage IA2 Lung Cancer AJCC v8; Stage IA3 Lung Cancer AJCC v8; Stage IB Lung Cancer AJCC v8; Stage II Colorectal Cancer AJCC v8; Stage II Lung Cancer AJCC v8; Stage IIA Colorectal Cancer AJCC v8; Stage IIA Lung Cancer AJCC v8; Stage IIB Colorectal Cancer AJCC v8; Stage IIB Lung Cancer AJCC v8; Stage IIC Colorectal Cancer AJCC v8; Stage III Colorectal Cancer AJCC v8; Stage III Lung Cancer AJCC v8; Stage IIIA Colorectal Cancer AJCC v8; Stage IIIA Lung Cancer AJCC v8; Stage IIIB Colorectal Cancer AJCC v8; Stage IIIB Lung Cancer AJCC v8; Stage IIIC Colorectal Cancer AJCC v8; Stage IIIC Lung Cancer AJCC v8

Summary: this phase iii trial studies how well a telehealth self-management program works in improving survivorship care and outcomes in stage i-iii non-small cell lung cancer or colorectal cancer survivors. survivor self-management program focuses on coaching patients on follow-up care after cancer treatments. participating in the program may improve knowledge and confidence about follow-up care, communication with cancer care and primary care doctors, and quality of life after cancer treatment in non-small cell lung cancer or colorectal cancer survivors.

primary objectives: i. determine the efficacy of the intervention on care coordination, communication, and primary care provider (pcp) knowledge, comparing the intervention and attention control arms at 4 and 8 months post-accrual. ii. determine the efficacy of the intervention on survivor outcomes, comparing the intervention and attention control arms at 4 and 8 months post-accrual. exploratory objective: i. assess the reach, efficacy, adoption, implementation, and maintenance (re-aim) of the intervention. outline: patients are randomized to 1 of 2 arms. arm i (survivor self-management): patients receive a personalized care plan/resource manual. patients also participate in 5 telehealth sessions with a nurse over 60 minutes each for 4 months (months 1-4) about self-management skills building, then 3 maintenance telehealth sessions with a nurse over 60 minutes each for 3 months (months 5-7) for additional self-management skills building support. a copy of patient's care plan is also sent to their pcp. arm ii (attention control): patients receive an american society of clinical oncology (asco) care plan. patients also participate in 5 telehealth sessions with a nurse over 60 minutes each for 4 months (months 1-4) to review a handbook about life after cancer treatment, then 3 monthly telehealth sessions with a nurse over 60 minutes each for 3 months (months 5-7) to answer questions about the handbook. a copy of the asco care plan is also sent to their pcp. after study initiation, patients are followed up at 4 and 8 months.

Eligibility criteria:
inclusion criteria: * non-small cell lung cancer (nsclc) and colorectal cancer survivors who are 4 months post-treatment completion * history of stage i-iii disease * ability to read or understand english * all subjects must have the ability to understand and the willingness to sign a written informed consent exclusion criteria: * subjects, who in the opinion of the principal investigator (pi), may not be able to comply with the requirements of the study